SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000921895-17-001120
Filing Date
2017-04-20
Accepted
2017-04-19 20:49:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO THE SCHEDULE 13D sc13da206922004_04192017.htm SC 13D/A 43883
  Complete submission text file 0000921895-17-001120.txt   45268
Mailing Address 611 SOUTH FORT HARRISON AVE SUITE 306 CLEARWATER FL 33756
Business Address
DUGGAN ROBERT W (Filed by) CIK: 0001055919 (see all company filings)

Type: SC 13D/A

Mailing Address 849 MITTEN ROAD SUITE 104 BURLINGAME CA 94010
Business Address 849 MITTEN ROAD SUITE 104 BURLINGAME CA 94010 650-697-3939
Pulse Biosciences, Inc. (Subject) CIK: 0001625101 (see all company filings)

IRS No.: 465696597 | State of Incorp.: NV | Fiscal Year End: 1217
Type: SC 13D/A | Act: 34 | File No.: 005-89516 | Film No.: 17771153
SIC: 3841 Surgical & Medical Instruments & Apparatus